Join date: Nov 2, 2021

About enables you to get the illustrated news stories on the latest and trending events. These stories cover news across diverse categories.

 Impavido® (miltefosine) is an FDA-approved treatment for cutaneous,  mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO 


More actions